Table 1. Comparison between azithromycin MDA treatment and control participants at baseline, Tanzania, January 12–July 21, 2009* .

Variable	MDA treatment group	MDA control group
Bednet ownership, yes/no†	457/725 (63)	328/789 (42)
History of fever, yes/no†	26/813 (3)	10/869 (1)
Malaria medication, yes/no	157/814 (19)	161/869 (19)
Latrine access, yes/no	297/981 (30)	276/971 (28)
Education of head of household, yes/no	4.2 (3.41)	3.2 (3.46)
Altitude, m	1,206 (32.89)	1,200 (45.99)

*Values are no. positive/no. tested (%) for categorical measures or mean (SD) for continuous measures. MDA, mass drug administration.
†p<0.05 by χ² test.